• PDF: Delivered by email usually within 24 to 48 UK business hours.

Blood Banking and Blood Products

Blood Banking and Blood Products

This report analyzes the worldwide markets for Blood Banking & Blood Products in US$ Million by the following Product Segments: Blood Components and Plasma Products (Whole Blood & Cellular Components, & Plasma Fractions), and Equipment, Blood Tests and Other Consumables (Includes blood screening and related QC function, but excludes patient diagnosis). The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for each region for the period 2007 through 2015. Also, a seven-year historic analysis is provided for these markets.

The report profiles 205 companies, including leading blood banks such as AABB, America's Blood Centers, American Red Cross, Canadian Blood Services, CorCell Companies, Inc., Cord Blood Registry, Japan Red Cross, Lifebank Corp, National Blood Foundation, New England Cord Blood Bank, Inc., New York Blood Center, and VITA 34 AG. Some of the leading players in Blood Bank Technology & Supplies also discussed in this report include Beckman Coulter Inc., Becton Dickinson and Company, BioMerieux SA, Caridian BCT, Inc., Chiron, CSL Behring LLC, Daxor Corporation, Fenwal Inc., Fresenius SE, Gambro AB, Gen-Probe Incorporated, Haemonetics Corp, Hemagen Diagnostics Inc., Immucor Inc., Kawasumi Laboratories, Inc., Olympus America, Inc., PharmaStem Therapeutics, Inc., Terumo Corporation, ThermoGenesis Corp., and Velico Medical, Inc. Leading Players discussed under the Plasma Fractionation segment include Baxter International Inc., Bio Products Laboratory, CSL Limited, CSL Bioplasma, Grifols, Kedrion, Laboratorie Francais du Fractionnement et des Biotechnologies, Octapharma, Sanquin, and Talecris Biotherapeutics.

Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

  • 1.INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
    • Study Reliability and Reporting Limitations
    • Disclaimers
    • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
    • Product Definitions and Scope of Study
    • Blood Components and Plasma Products
    • Whole Blood & Cellular Components
    • WBCs
    • RBCs
    • Platelets
    • Plasma Fractions
    • Fresh Frozen Plasma
    • Albumin Fractions
    • Factor VIII
    • Factor IX and Factor IX Complex
    • Fibrin/Thrombin
    • Equipment, Blood Tests and Consumables
    • Automated Analyzers for Blood Analysis
    • Blood Tests
    • Consumables
  • 2.MARKET OVERVIEW
    • Healthcare Scares Propel the Market
    • Blood Transfusion Worldwide: A Kaleidoscope of Stark Contrasts
    • Worldwide Blood Banking and Blood Products Market at a Glance (All figures are 2010 estimates & CAGR is for the period 2007-2015)
    • Current & Future Analysis
    • Analysis by Geographic Region
    • Analysis by Product Segment
    • World Blood Components and Plasma Market Analysis in Units
    • Table 1: World Recent Past, Current & Future Analysis for Blood Components and Plasma by Region/Country - USA, Europe, Japan, and Rest of World Markets Independently Analyzed with Annual Consumption in Million Units for Years 2007 through 2015 (includes corresponding Graph/Chart)
    • Table 2: World 9-Year Perspective for Blood Components and Plasma by Region/Country - Percentage Breakdown of Volume Consumption for USA, Europe, Japan, and Rest of World Markets for Years 2007, 2010 & 2015 (includes corresponding Graph/Chart)
    • Red Blood Cells - A Key Blood Component and a Major Contributor
    • Table 3: World Recent Past, Current & Future Analysis for Red Blood Cells by Region/Country - USA, Europe, Japan, and Rest of World Markets Independently Analyzed with Annual Consumption in Million Units for Years 2007 through 2015 (includes corresponding Graph/Chart)
    • Table 4: World 9-Year Perspective for Red Blood Cells by Region/Country - Percentage Breakdown of Volume Consumption for USA, Europe, Japan, and Rest of World Markets for Years 2007, 2010 & 2015 (includes corresponding Graph/Chart)
  • 3.MARKET TRENDS & ISSUES
    • New Infections - A Continuous Threat
    • Safety and Availability: The Core Issues
    • Decontamination: A Viable Process
    • New Processes for Safer Blood Supply
    • Innovative Procedures Help Blood Conservation
    • Autologous Transfusion Strapping up for High Growth
    • Enzyme Converted Cells Set to Rule the Industry
    • Blood Unavailability: Substitutes to the Rescue
    • Transfusions: Hospitals Making Way for Others
    • Computer Identification Helps Patients
    • SARS: A Case of Mistaken Identity?
    • Pooling: Economical HIV Testing
    • Private Cord Blood Banking: Flying High Despite Opposition
    • Consolidation Whittles Down Number of Market Players
    • Table 5: Leading Players in the Global Blood Screening Market (2008) (includes corresponding Graph/Chart)
    • Table 6: Leading Players in the Global Plasma Derived Products Market (2008): Market Share in terms of Revenues for Baxter, CSL, Octapharma, Talecris and Grifols (includes corresponding Graph/Chart)
    • Table 7: Market Shares of CSL Behring and Talecris in Select Plasma Product Markets in terms of Revenues (2008) (includes corresponding Graph/Chart)
    • Automation of Blood Banking - Nearing the Efficiency Frontier?
    • Automated Instrumentation Taking the Front Seat
    • Table 8: World Market for Blood Bank Technology (2007): Percentage Breakdown of Revenues by Segment - Manual Blood Bag Systems, Automated Systems, Component Lab, Commercial Plasma, Blood Salvage, and Pathogen Inactivation (includes corresponding Graph/Chart)
    • Table 9: Leading Players in the World Market for Automated Collection of Blood Components using Apheresis Technology (2005 - A Historic Review): Percentage Breakdown of Revenues for Gambro, Baxter, Haemonetics, Fresenius, and Others (includes corresponding Graph/Chart)
    • Plasma Market: Automation Making Inroads
    • The RBC Market - Slow to Catch Up
    • Automation of Testing - Yet to Mature
    • Automation to Suffice Shortage Problems
    • How Near to the Efficiency Frontier?
  • 4.PRODUCT OVERVIEW
    • Blood Banking and Blood Products Industry
    • Blood Components and Plasma Products
    • Equipment, Blood Tests and Consumables
    • Automated Analyzers for Blood Analysis
    • Blood Tests
    • Consumables
    • Blood Collection Equipment
    • Blood Collection Monitors
    • Blood Donor Couches
    • Blood Processing Equipment
    • Blood Bank Centrifuges
    • Plasma Thawing
    • Blood Cell Separators
    • Blood Storage Equipment
    • Blood Bags
    • Platelet Agitators
    • Blood Bank Refrigerators
    • Blood - A Primer
    • Ionic Structure
    • Blood Components and their Applications
    • Blood Constituents
    • Plasma
    • Red Blood Cells (RBC)
    • Blood Count
    • Platelets
    • Table 10: Platelets (Leucodepleted) Issued by Select Region/ Agency (2005) (includes corresponding Graph/Chart)
    • White Blood Cells (WBC)
    • Derivative Products of Blood or Plasma Fractions
    • Plasma Protein and Fractionation
    • The Need
    • Fresh Frozen Plasma
    • Other Plasma Fractions
    • Albumin Fractions
    • Albumin Usage Rising in Profile, Wastage Worries Run Deep
    • Immunoglobulins
    • Table 11: Leading Countries in IVIg Usage Rates in Grams per 1000 Population (includes corresponding Graph/Chart)
    • Hyper-Immune Immunoglobulin
    • Factor VIII
    • Table 12: Leading Players in World Market for Factor VIII (2006): Percentage Breakdown of Revenues for Baxter, Bayer (Kogenate), CSL Behring (Helixate) and Wyeth (includes corresponding Graph/Chart)
    • Factor IX and Factor IX Complex
    • Fibrin/Thrombin
    • Consumption of Blood Based on Type of Surgery/ Accident (In Units)
    • Table 13: World Market for Plasma Derivatives (2009): Percentage Breakdown of Revenues by Region/Country - USA, Europe, Asia-Pacific, Latin America, and Rest of World (includes corresponding Graph/Chart)
    • Table 14: World Market for Plasma Derivatives (2006): Percentage Breakdown of Revenues by Product Type - IVIg, Factor VIII, Albumin, Hyperimmunes, Factor IX and Others (includes corresponding Graph/Chart)
    • Table 15: Plasma Collection in Select Countries in Thousand Liters (includes corresponding Graph/Chart)
    • Recombinant Products
    • Therapeutic Uses of Plasma Products
    • Albumin Products
    • Immunoglobulins
    • Intravenous Immunoglobulin (IVIg)
    • Normal Immunoglobulin (IMIg)
    • CMV Immunoglobulin
    • Hepatitis B Immunoglobulin
    • Rh (D) Immunoglobulin
    • Tetanus Immunoglobulin IM
    • Zoster Immunoglobulin
    • Plasma Derived Coagulant Products
    • Biostate®
    • Ceprotin®
    • Factor VII Concentrate
    • Factor XI Concentrates
    • Feiba VH® Inhibitor Treatment
    • Fibrogammin P®
    • Monofix®-VF
    • ProthrombinexTM-HT
    • Thrombotrol®-VF
  • 5.BLOOD COLLECTION METHODS
    • Banking the Natural Blood Resources
    • Blood Banks
    • Blood Banking
    • Blood Transfusion
    • Role of Blood Banks
    • Blood Donor: The Epicenter of the Process
    • Eligibility Criteria for the Donor
    • The Basics of Blood Donation - Myths Exploded & Other Facts
    • Table 16: Active Donors of Whole Blood and Apheresis per 1,000 of Population by Country/Agency (includes corresponding Graph/Chart)
    • Table 17: Percentage Breakdown of Apheresis and Whole Blood Donations by Country (2005) (includes corresponding Graph/Chart)
    • Collection Methods
    • Blood Donation: The Process
    • Types of Blood Donation
    • Directed Blood Donations
    • Autologous Blood Donation
    • Alternative Usage of Patient's Own Blood
    • General Blood Donation
    • Hemodilution
    • Wound Drainage
    • Cell Saver
    • The Method
    • Blood Salvaging
    • Blood Collection Centers
    • Blood Collection Management System
    • A Historical Retrospective
    • Blood Collection Centers
    • Types of Blood Collection Centers
    • Cord Blood Banks
    • Profit Collection Centers
    • Military Blood Banks
    • Hospital Blood Banks
    • Community Blood Banks
    • Non-Profit Collection Centers
    • Blood Processing
    • Blood Typing
    • Rh Blood Group System
    • ABO Blood Group System
    • Blood Types and their Compatibility
    • Table 18: Occurrence of Blood Groups Worldwide (In %) (includes corresponding Graph/Chart)
    • Blood Test
    • Blood Culture
    • The Costs
    • History of Blood Banking
  • 6.THE CHANGING LANDSCAPE OF TRANSFUSION TECHNOLOGIES & TESTS
    • Blood Transfusion: A Backdrop
    • Massive Transfusion
    • Complications and Risks Due to Transfusion
    • Circulatory Overload
    • Graft Versus Host Disease (GVHD)
    • Haemolytic Transfusion Reactions
    • Iron Overload
    • Bacterial Contamination
    • Thrombophlebitis
    • Allergic Reactions
    • Air Embolism
    • Hyperkalaemia
    • Changing Role of Blood Banking Technology
  • 7.BLOOD TRANSFUSION: THE PROCESS, TESTS/TECHNOLOGIES
    • Cross Matching
    • Blood Donor/Recipient Screening
    • Blood Typing
    • Leukoreduction
    • Leukocyte Reduction Specification Standards/Filters
    • Coombs Test
  • 8.ALTERNATIVES TO BLOOD TRANSFUSION: A REAL THREAT TO THE INDUSTRY
    • Bloodless Surgery
    • Therapeutic Apheresis
    • Plasmapheresis
    • Plateletpheresis
    • Leukapheresis
    • Volume Expanders
    • Colloids
    • Albumin
    • Dextrans
    • Hydroxyethyl Starch
    • Crystalloids
    • Blood Growth Factor Therapies - Newer Alternatives to Transfusion
  • 9.BLOOD SUBSTITUTES
    • Blood Substitutes Under Development by Manufacturers
    • Synthetic Blood Manufacturers/Developers
    • Alliance Pharmaceuticals Corp. (USA)
    • Biopure Corporation (USA)
    • Enzon Pharmaceuticals (USA)
    • Hemosol Inc. (Canada)
    • Northfield Laboratories Inc. (USA)
    • Synthetic Blood International, Inc. (USA)
  • 10.PRODUCT INTRODUCTIONS/INNOVATIONS
    • Fenwal Receives US FDA Clearance for Fenwal Amicus® Separator System
    • FamilyCord Introduces New More Efficient and Safe Cord Blood Collection Kit
    • BD Unveils BD Microtainer® MAP Microtube
    • Pall Releases Advanced Blood Filter
    • Fenwal Responds to Haemonetics' New Lawsuit Against Alyx® System
    • CaridianBCT Rolls Out RBCX Protocol
    • ITL Launches TEGO™ Animal Blood Collection Kit
    • Fenwal to Launch Modified ALYX Kit
    • QIAGEN Launches New QIAsafe DNA Blood Products
    • Gambro Introduces New Prismaflex eXeed™ System
    • AnaSpec Unveils 'SensoLyte® Rh110 Plasmin Activity Assay Kit
    • Typenex® Medical Rolls Out New Barcode Blood Band
    • Olympus Introduces Hemoglobin A1c APT Reagent for Chemistry Analyzer System
    • BD Diagnostics Launches BD BACTEC™ FX Blood Culture System
    • Beckman Coulter Launches UniCel DxH 800 Coulter® Cellular Analysis System
    • Diazyme Secures FDA Clearance for Marketing Liquid Stable Enzymatic Lithium Test
    • ThermoGenesis Launches New Range of Veterinary POC Products
    • Prometheus Develops First Blood Test for IBS Diagnosis
    • CaridianBCT Introduces 'Atreus® 3C Whole Blood Processing System'
    • GeneNews Unveils ColonSentry™ for Diagnosing Colorectal Cancer
    • Haemonetics Upgrades PCS®2 System with Quicker Plasma Collection Software
  • 11.PRODUCT INNOVATIONS/LAUNCHES IN RECENT PAST - A PERSPECTIVE BUILDER
    • Olympus Launches AU680® Chemistry Analyzer
    • Haemonetics Software Expands Symphony 2.0 Software with New Module71Gen-Probe Introduces APTIMA® HPV Assay
    • Olympus Life Science Europa Introduces Automated HbA1c Assay
    • Haemonetics Unveils New Plasma Collection Software
    • Pall Unveils Acrodose™ PLus System
    • Z-Medica Rolls Out Rapid Blood Clotting Products in the Consumer Market
    • Dade Behring Launches the Quadriga BeFree System
    • Swedish Inventors Develop New Processing System
    • Canada Invents New Method for Monitoring Blood and Blood Products
    • Terumo Launches Improvised Bags For Safe Blood Collection
    • Haemonetics Launches Cymbal Automated Blood Collection System
  • 12.PRODUCT APPROVALS IN THE RECENT PAST
    • Cerus Receives CE Mark Approval for the Intercept Blood System for Platelets
    • Haemonetics Wins FDA Approval for the ACP 215 System
    • Biomerieux' Polycarbonate BacT/ALERT Receives US FDA Clearance
    • Pall's eBDS Receives Green Signal from FDA
    • CardioPAT™ Surgical Blood Salvage System
    • PCS® 2 - Set to Enhance Plasma Quality
    • Dade Behring's D-Dimer Assay Strapping up for Roll Out
  • 13.RECENT INDUSTRY ACTIVITY
    • HemaCare Signs Two New Blood Service Contracts
    • Cord Blood Acquires Majority Stake in Stellacure
    • Haemonetics Gains Rights to Alba's Full Line of Blood Typing Reagents
    • ThermoGenesis Inks Deal with Fenwal and Enters Asian Markets
    • CaridianBCT Obtains FDA Approval for New 6.0 Trima Accel® Automated Blood Collection System
    • American Red Cross Inks 3-Year Deal with ITL
    • FDA Grants 510(K) Clearance for Expanded Use of Haemonetics
    • ThermoGenesis and GE Healthcare Enter into Distribution Deal
    • Daxor's Idant Labs Bags Blood Banking Contract from RMSB&G
    • Beckman Coulter Agrees to Distribute CellaVision Digital Morphology Products
    • Haemonetics to Acquire Global Med
    • Therapure Biopharma Inks Long Term Pact with LFB Biomedicaments
    • PathCare Establishes New Cord Blood Stem Cell Banking Facility
    • MRHC Obtains License for SafeTrace Tx Solution of Global Med
    • Life Technologies to Acquire AcroMetrix
    • Fenwal Secures FDA Approval for New Platelet Additive Solution
    • Daxor Sells Blood Volume Analyzer to MUSC
    • Heska Enters into a Supply Agreement with Roche Diagnostics
    • BLOOD Bank of Alaska Obtains License for Mediware's LifeTrak Technology
    • Europe and the US Expand Blood Banking Agreement
    • Daxor to Provide BVA-100 Blood Volume Analyzer to Durham VA Medical Center
    • Pfizer Acquires Wyeth
    • Baxter Inaugurates New BLOOD Plasma Fractionation Facility in Vienna
    • ProMetic Acquires Majority Shareholding in PRDT
    • BD Diagnostics Bags FDA Approval for BD Vacutainer® Rapid Serum Tube
    • Cadila to Establish Biosimilars Manufacturing Plant
    • China Biologic to Collaborate with IBT on Research & Development
    • Abbott Obtains FDA Approval for Abbott Prism HIV O Plus Test
    • Gen-Probe to Establish Independent New Firm for Industrial Testing
    • Haemonetics Acquires SEBRA Blood Collection & Processing Unit
    • Beckman Coulter Acquires Lab-Based Diagnostics Business of Olympus
    • Daxor to Provide BVA-100 Blood Volume Analyzer to Pacific Cardiology
    • Golden Meditech and Fenwal to Establish a Blood Collection Joint Venture in China
    • PRCS Inaugurates State-of-the-Art Blood Bank
    • CSL and Talecris Terminate Merger Agreement
    • Immucor Inks 5-Year Deal with Alverno
    • Gen-Probe Acquires Tepnel and Renews Partnership with Novartis
    • Haemonetics Takes Over Neoteric Technology
    • Haemonetics Acquires Altivation Software
    • PacifiCord Sets Up Cord Blood Banking Facility in Irvine
    • China Biologic Acquires 35% Stake in Xi`an Huitian Blood Products
    • Biocell and Cellsense Merge
    • Octapharma Plans to Set Up Fractionation Facility
    • Therapure BioPharma Inks Development Services Deal with LFB Biotechnologies
    • Strassenburg and CordLife to Establish Blood Banking Facility in Kolkata, India
    • Biotest Acquires Blood Plasma Collection Center from Talecris
    • NCRM and Jeevan Stem Cell Bank Signs MoU for Cord Blood Stem Cells Research
    • TCH of Tahlequah Acquires Daxor's BVA-100 Blood Volume Analyzer
    • Gen-Probe Expands and Extends Blood Screening Alliance with Novartis
    • Celestial Biologicals Collaborates With GE Healthcare for Indian Market
    • China Biologic to Purchase Stake in Dalin
    • Cerus Enters Into Deal with Fenwal
    • Bennnett, Coleman Picks Up Minority Stake in Stem One Biologicals
    • Cryo-Cell Renews Exclusive Retailer Agreement with Upromise®
    • Pantheon China to Take Over China Cord Blood Services
    • United Blood Services to Divest Jackson Operations to Mississippi Blood Services
    • ITL Signs Agreement with Blood Centers of America
    • CaridianBCT Mirasol PRT System Receives CE Mark Approval
    • CaridianBCT Signs Deal with American Red Cross for Automated Blood Collection Technology
    • Genzyme Japan to Acquire Lymphoglobuline Marketing from CSL Behring
    • Biotest Diagnostics and GSABC Ink a Deal
    • Blood Cell Storage Inks Option Agreement With CaridianBCT
    • CBB Inaugurates Donor Facility In Indio
    • CSL to Acquire Talecris
    • Novartis Diagnostics Gains FDA Clearance for PROCLEIX® ULTRIO® Assay
    • ViaCord to Collaborate with Mia Hamm Foundation
    • Octapharma to Take Over Plasma Centers from International BioResources
    • America's Blood Centers and MDA Ink a Contingency Deal
    • Piramal Healthcare Enters into an Agreement with PlasmaSelect
    • Grifols Secures Commercial Loan for Purchasing Plasma Centres
    • Cytori Inks Supplying Agreement with Biohellenika
    • Animal Blood Bank and Midwest Animal Blood Services Merge to Form Animal Blood Resources
    • Gambro Gains FDA Approval for Sale of Atreus®
    • Cerus Signs Agreement for INTERCEPT Platelet System Supply
    • Haemonetics Teams Up with Octapharma for Plasma Collection Technology
    • Gambro Inks Deal with S.C.M to Divest Its Bloodline manufacturing Unit
    • Octapharma Acquires PVG
  • 14.CORPORATE ACTIVITY IN RECENT PAST - A PERSPECTIVE BUILDER
  • 15.FOCUS ON SELECT GLOBAL PLAYERS
    • Leading Blood Banks
    • AABB (USA)
    • America's Blood Centers (USA)
    • American Red Cross (USA)
    • Canadian Blood Services (Canada)
    • CorCell Companies Inc. (USA)
    • Cord Blood Registry (USA)
    • Japan Red Cross Society (Japan)
    • Lifebank Corp. (Canada)
    • National Blood Foundation (USA)
    • New England Cord Blood Bank, Inc. (USA)
    • New York Blood Center (USA)
    • VITA 34 AG (Germany)
    • Leading Players in Blood Bank Technology and Supplies
    • Beckman Coulter, Inc. (USA)
    • Becton, Dickinson and Company (USA)
    • BioMerieux SA (France)
    • Caridian BCT, Inc (USA)
    • Chiron (USA)
    • CSL Behring LLC (USA)
    • Daxor Corporation (USA)
    • Fenwal Inc., (USA)
    • Fresenius SE (Germany)
    • Gen-Probe, Inc. (USA)
    • Haemonetics Corp. (USA)
    • Hemagen Diagnostics Inc. (USA)
    • Immucor Inc. (USA)
    • Kawasumi Laboratories, Inc. (Japan)
    • PharmaStem Therapeutics, Inc. (USA)
    • Terumo Corp. (Japan)
    • ThermoGenesis Corp. (USA)
    • Velico Medical, Inc. (USA)
    • Leading Players in Plasma Fractionation
    • Baxter International Inc. (USA)
    • Bio Products Laboratory (UK)
    • CSL Limited (Australia)
    • CSL Bioplasma (Australia)
    • Grifols (Spain)
    • Kedrion (Italy)
    • Laboratoire Français du Fractionnement et des Biotechnologies (France)
    • Octapharma (Switzerland)
    • Sanquin (The Netherlands)
    • Talecris Biotherapeutics (USA)
  • 16.GLOBAL MARKET PERSPECTIVE
    • Table 19: World Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
    • Table 20: World Historic Review for Blood Banking and Blood Products by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)
    • Table 21: World 10-Year Perspective for Blood Banking and Blood Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)
    • Table 22: World Recent Past, Current & Future Analysis for Blood Components and Plasma Products by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
    • Table 23: World Historic Review for Blood Components and Plasma Products by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)
    • Table 24: World Recent Past, Current & Future Analysis for Blood Components and Plasma Products by Product Group - Whole Blood & Cellular Components, and Plasma Fractions Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
    • Table 25: World Historic Review for Blood Components and Plasma Products by Product Group - Whole Blood & Cellular Components, and Plasma Fractions Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)
    • Table 26: World 10-Year Perspective for Blood Components and Plasma Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)
    • Table 27: World 10-Year Perspective for Blood Components and Plasma Products by Product Segment - Percentage Breakdown of Value Sales for Whole Blood & Cellular Components, and Plasma Fractions Markets for Years 2005, 2010 & 2015
    • Table 28: World Recent Past, Current & Future Analysis for Whole Blood & Cellular Components by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
    • Table 29: World Historic Review for Whole Blood & Cellular Components by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)
    • Table 30: World 10-Year Perspective for Whole Blood & Cellular Components by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)
    • Table 31: World Recent Past, Current & Future Analysis for Plasma Fractions by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
    • Table 32: World Historic Review for Plasma Fractions by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)
    • Table 33: World 10-Year Perspective for Plasma Fractions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)
    • Table 34: World Recent Past, Current & Future Analysis for Equipment, Blood Tests and Other Consumables by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
    • Table 35: World Historic Review for Equipment, Blood Tests and Other Consumables by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)
    • Table 36: World 10-Year Perspective for Equipment, Blood Tests and Other Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)
  • 17.THE UNITED STATES
    • A. Market Analysis
    • Current and Future Analysis
    • Market Trends
    • Recession Impacts Blood Bank Reserves
    • US Blood Collection & Supply Profile
    • Blood Group Distribution
    • Table 37: US Market for Blood Banking and Blood Products: Percentage Break up of Blood Group by Rh Factor (includes corresponding Graph/Chart)
    • Table 38: Percentage Break up of Rh Blood Types in the US by Racial Group
    • Blood Donated and Transfused Every Year
    • Males Form the Major Chunk of Donors
    • Cost of Blood
    • SARS Scares: Blood Banks Feel the Heat
    • Blood and Blood Preparations: A Recent Past Review of Trade Statistics
    • Table 39: US Blood and Blood Preparations Market (2006 & 2007): Major Import Sources by Country - Germany, UK, Canada, Switzerland, Belgium and Others (In US$ Million) (includes corresponding Graph/Chart)
    • Table 40: US Blood and Blood Preparations Market (2006 & 2007): Major Export Destinations by Country - Germany, Netherlands, UK, Switzerland, Canada and Others (In US$ Million) (includes corresponding Graph/Chart)
    • US Blood Components and Plasma Market Analysis in Units
    • Table 41: US Recent Past, Current & Future Analysis for Blood Components and Plasma by Product Category - Red Blood Cells (RBCs), Platelets, and Fresh Frozen Plasma Markets Independently Analyzed with Annual Consumption in Million Units for Years 2007 through 2015 (includes corresponding Graph/Chart)
    • Table 42: US Historic Review for Blood Components and Plasma by Product Category - Red Blood Cells (RBCs), Platelets, and Fresh Frozen Plasma Markets Independently Analyzed with Annual Consumption in Million Units for Years 2001 through 2006 (includes corresponding Graph/Chart)
    • Table 43: US 10-Year Perspective for Blood Components and Plasma by Product Category - Percentage Breakdown of Volume Consumption for Red Blood Cells (RBCs), Platelets, and Fresh Frozen Plasma for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)
    • Regulations Control Plasma Collection Industry
    • B. Market Analytics
    • Table 44: US Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/ Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
    • Table 45: US Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood and Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)
    • Table 46: US 10-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)
  • 18.CANADA
    • A. Market Analysis
    • Current and Future Analysis
    • Blood Facts
    • Bleeding Disorders - A Major Threat
    • The 'CSA-Z902-04' - A Comprehensive Voluntary Blood Safety Standard
    • Blood and Blood Preparations: Import & Export Scenario in the Recent Past
    • Table 47: Canadian Blood and Blood Preparations Market (2006 & 2007): Major Import Sources by Country - US, The Netherlands, Switzerland, Belgium, Italy and Others (In US$ Million) (includes corresponding Graph/Chart)
    • Table 48: Canadian Blood and Blood Preparations Market (2006 & 2007): Major Export Destinations by Country - US, France, Chile, Belgium, Germany and Others (In US$ Million) (includes corresponding Graph/Chart)
    • B. Market Analytics
    • Table 49: Canadian Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
    • Table 50: Canadian Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)
    • Table 51: Canadian 10-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)
  • 19.JAPAN
    • A. Market Analysis
    • Current and Future Analysis
    • Japan Witnesses Surge in Imported Blood Products
    • Growing Market for Fresh Frozen Plasma
    • Growing Use of Imported Albumin-Based Blood Products
    • The Goal of Self-Sufficiency
    • B. Market Analytics
    • Table 52: Japanese Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
    • Table 53: Japanese Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)
    • Table 54: Japanese 10-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)
  • 20.EUROPE
    • A. Market Analysis
    • Current & Future Analysis
    • European Blood Banking and Blood Products Market at a Glance (All figures are 2010 estimates & CAGR is for the period 2007-2015)
    • Market Trends and Issues
    • Legislations on Payment for Donation Restrict Donors
    • Government's Check on Healthcare Costs Pressurizes BCT Manufacturers
    • Purchasing System Witnesses Modifications
    • EU Nations Marching Towards Self-Sufficiency in Blood and Blood Products
    • Blood Banking Devices Market
    • Table 55: European Recent Past, Current & Future Analysis for Blood Banking Devices - Manual Blood Collection, Apheresis, and Autologous Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
    • Table 56: European Historic Review for Blood Banking Devices - Manual Blood Collection, Apheresis, and Autologous Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)
    • Table 57: European 10-Year Perspective for Blood Banking Devices by Product Segment - Manual Blood Collection, Apheresis, and Autologous Devices Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)
    • Table 58: European Blood Banking Devices Market (2007): Percentage Breakdown of Value Sales by Geographic Region for France, Germany, Italy, UK, Spain and Rest of Europe (includes corresponding Graph/Chart)
    • A Snapshot of Health Care Systems Across Select EU Countries
    • France
    • Germany
    • Italy
    • The UK
    • Spain
    • B. Market Analytics
    • Table 59: European Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
    • Table 60: European Historic Review for Blood Banking and Blood Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)
    • Table 61: European Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/ Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
    • Table 62: European Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)
    • Table 63: European 10-Year Perspective for Blood Banking and Blood Products by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)
    • Table 64: European 10-Year Perspective for Blood Banking and Blood Products by Product Group/ Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)
  • 20a.FRANCE
    • A. Market Analysis
    • Current and Future Analysis
    • B. Market Analytics
    • Table 65: French Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/ Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
    • Table 66: French Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)
    • Table 67: French 10-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)
  • 20b.GERMANY
    • A. Market Analysis
    • Current and Future Analysis
    • B. Market Analytics
    • Table 68: German Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
    • Table 69: German Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)
    • Table 70: German 10-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)
  • 20c.ITALY
    • A. Market Analysis
    • Current and Future Analysis
    • B. Market Analytics
    • Table 71: Italian Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group /Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
    • Table 72: Italian Historic Review for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)
    • Table 73: Italian 10-Year Perspective for Blood Banking and Blood Products by Product Group/ Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)
  • 20d.THE UNITED KINGDOM
    • A. Market Analysis
    • Current and Future Analysis
    • Blood Requirements
    • B. Market Analytics
    • Table 74: The UK Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/ Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
    • Table 75: The UK Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumable Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)
    • Table 76: The UK 10-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)
  • 20e.SPAIN
    • A. Market Analysis
    • Current and Future Analysis
    • B. Market Analytics
    • Table 77: Spanish Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/ Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding graph/Chart)
    • Table 78: Spanish Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)
    • Table 79: Spanish 10-Year Perspective for Blood Banking and Blood Products by Product Group/ Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)
  • 20f.RUSSIA
    • Market Analysis
    • Table 80: Russian Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/ Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
    • Table 81: Russian Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)
    • Table 82: Russian 10-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)
  • 20g.REST OF EUROPE
    • A. Market Analysis
    • Current and Future Analysis
    • Denmark - High Participation and Consumption of Blood
    • B. Market Analytics
    • Table 83: Rest of Europe Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
    • Table 84: Rest of Europe Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)
    • Table 85: Rest of Europe 10-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)
  • 21.ASIA-PACIFIC
    • A. Market Analysis
    • Current and Future Analysis
    • ASEAN - Striding Towards Standardization of Blood Supply
    • China - A Key Market
    • Blood Products Industry - An Overview
    • Performance Review
    • Volume Declines But Revenues Shoot Up in Chinese Blood Products Market
    • Government Wakes Up to Realities
    • Table 86: Chinese Market for Blood Banking and Blood Products: Percentage Breakdown of Blood Group by Type - A, B, O, and AB (includes corresponding Graph/Chart)
    • Table 87: Chinese Market for Blood Banking and Blood Products: Percentage Breakdown of Blood Donor by Gender - Male and Female
    • Table 88: Chinese Blood Banking and Blood Products Market: Percentage Breakdown of Blood Donor by Age Group - 16-20, 21-30, 31-40, 41-50, 51-60, & 61-70 (includes corresponding Graph/Chart)
    • India
    • Blood Banking Equipment Market on the Rise
    • Tube Sealers and Blood Bags Dominate the Market
    • Recent Trends in the Market
    • Indian Blood Banking Market Witnesses Major Transformations
    • Market Growth - Influencing Factors
    • Increased Awareness Drives Voluntary Blood Donations in India
    • Competitive Scenario
    • Regularization of Indian Cord Blood Banks
    • Australia
    • Role of National Blood Authority
    • Indonesia
    • B. Market Analytics
    • Table 89: Asia-Pacific Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
    • Table 90: Asia-Pacific Historic Review for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)
    • Table 91: Asia-Pacific 10-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)
  • 22.LATIN AMERICA
    • A. Market Analysis
    • Current and Future Analysis
    • B. Market Analytics
    • Table 92: Latin American Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
    • Table 93: Latin American Historic Review for Blood Banking and Blood Products by Product Group/ Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)
    • Table 94: Latin American 10-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)
  • 23.REST OF WORLD
    • A. Market Analysis
    • Current and Future Analysis
    • B. Market Analytics
    • Table 95: Rest of World Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
    • Table 96: Rest of World Historic Review for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)
    • Table 97: Rest of World 10-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)
  • Total Companies Profiled: 205 (including Divisions/Subsidiaries - 315)
    • Region/CountryPlayers
    • The United States136
    • Canada
    • Japan
    • Europe
    • France
    • Germany
    • The United Kingdom
    • Italy
    • Spain
    • Rest of Europe
    • Asia-Pacific (Excluding Japan)
    • Latin America
    • Africa
    • Middle East
+44 20 8816 8548

Ask a question about Blood Banking and Blood Products

Enter the characters you see in the picture below
Captcha